Phase I/II trials of (186)Re-HEDP in metastatic castration-resistant prostate cancer: post-hoc analysis of the impact of administered activity and dosimetry on survival

PURPOSE: To investigate the role of patient-specific dosimetry as a predictive marker of survival and as a potential tool for individualised molecular radiotherapy treatment planning of bone metastases from castration-resistant prostate cancer, and to assess whether higher administered levels of act...

Descripción completa

Detalles Bibliográficos
Autores principales: Denis-Bacelar, Ana M., Chittenden, Sarah J., Dearnaley, David P., Divoli, Antigoni, O’Sullivan, Joe M., McCready, V. Ralph, Johnson, Bernadette, Du, Yong, Flux, Glenn D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323472/
https://www.ncbi.nlm.nih.gov/pubmed/27770145
http://dx.doi.org/10.1007/s00259-016-3543-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323472/
https://www.ncbi.nlm.nih.gov/pubmed/27770145
http://dx.doi.org/10.1007/s00259-016-3543-x

Ejemplares similares